Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ETS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UNC13C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPRIN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC42SE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SRP72 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CFLAR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM92A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC30A9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C11orf57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBCK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB11FIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAMTOR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on